Intravenous Ketamine for Cancer Pain Management, Including Flares During the COVID-19 Pandemic: A Retrospective Study.

Daniel Chun-Suk OhPaul HaffeyAnkur PatelAmitabh Gulati

Published in: Pain medicine (Malden, Mass.) (2021)

Intravenous ketamine may be a safe and effective adjuvant treatment for CNP, especially with serotonin-norepinephrine reuptake inhibitors. Larger, prospective studies are warranted and should explore parameters to help prognosticate response to ketamine infusions.

Keyphrases

pain management
chronic pain
high dose
early stage
combination therapy
childhood cancer